Structure

Physi-Chem Properties

Molecular Weight:  446.19
Volume:  438.017
LogP:  1.374
LogD:  0.948
LogS:  -3.776
# Rotatable Bonds:  5
TPSA:  119.36
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  6
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.378
Synthetic Accessibility Score:  7.099
Fsp3:  0.708
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.123
MDCK Permeability:  6.165008380776271e-05
Pgp-inhibitor:  0.102
Pgp-substrate:  0.111
Human Intestinal Absorption (HIA):  0.263
20% Bioavailability (F20%):  0.647
30% Bioavailability (F30%):  0.983

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.694
Plasma Protein Binding (PPB):  30.546552658081055%
Volume Distribution (VD):  1.145
Pgp-substrate:  58.55620574951172%

ADMET: Metabolism

CYP1A2-inhibitor:  0.014
CYP1A2-substrate:  0.112
CYP2C19-inhibitor:  0.018
CYP2C19-substrate:  0.225
CYP2C9-inhibitor:  0.009
CYP2C9-substrate:  0.012
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.077
CYP3A4-inhibitor:  0.623
CYP3A4-substrate:  0.238

ADMET: Excretion

Clearance (CL):  2.247
Half-life (T1/2):  0.543

ADMET: Toxicity

hERG Blockers:  0.103
Human Hepatotoxicity (H-HT):  0.053
Drug-inuced Liver Injury (DILI):  0.347
AMES Toxicity:  0.323
Rat Oral Acute Toxicity:  0.895
Maximum Recommended Daily Dose:  0.848
Skin Sensitization:  0.396
Carcinogencity:  0.569
Eye Corrosion:  0.004
Eye Irritation:  0.029
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC320118

Natural Product ID:  NPC320118
Common Name*:   Maoesin D
IUPAC Name:   n.a.
Synonyms:   Maoesin D
Standard InCHIKey:  FUWZKRPAEKGTSW-MIWKWXCYSA-N
Standard InCHI:  InChI=1S/C24H30O8/c1-12-15-5-6-16-22-8-7-17(32-14(3)26)21(4,10-30-13(2)25)18(22)20(28)24(29,31-11-22)23(16,9-15)19(12)27/h5-6,15-18,20,28-29H,1,7-11H2,2-4H3/t15-,16+,17+,18-,20+,21-,22-,23+,24+/m1/s1
SMILES:  CC(=O)OC[C@]1(C)[C@H](CC[C@@]23[C@@H]1[C@H](O)[C@](O)(OC2)[C@]12[C@H]3C=C[C@H](C1)C(=C)C2=O)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1641877
PubChem CID:   50901151
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1927 Isodon eriocalyx Species Lamiaceae Eukaryota n.a. leaf n.a. PMID[17020288]
NPO1927 Isodon eriocalyx Species Lamiaceae Eukaryota n.a. aerial part n.a. PMID[20949916]
NPO1927 Isodon eriocalyx Species Lamiaceae Eukaryota aerial parts n.a. n.a. PMID[20949916]
NPO1927 Isodon eriocalyx Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[22624550]
NPO1927 Isodon eriocalyx Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens IC50 = 7300.0 nM PMID[482362]
NPT181 Cell Line Bel-7402 Homo sapiens IC50 > 10000.0 nM PMID[482362]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 > 10000.0 nM PMID[482362]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC320118 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9623 High Similarity NPC194273
0.9352 High Similarity NPC243354
0.9252 High Similarity NPC471243
0.9245 High Similarity NPC131903
0.9182 High Similarity NPC218970
0.9159 High Similarity NPC137104
0.9159 High Similarity NPC474786
0.9159 High Similarity NPC85391
0.9159 High Similarity NPC320383
0.9151 High Similarity NPC471094
0.9151 High Similarity NPC473410
0.9151 High Similarity NPC469984
0.9143 High Similarity NPC56656
0.9074 High Similarity NPC213320
0.9065 High Similarity NPC274827
0.9065 High Similarity NPC102741
0.9057 High Similarity NPC471474
0.9009 High Similarity NPC470171
0.8991 High Similarity NPC473397
0.8991 High Similarity NPC474927
0.8991 High Similarity NPC205534
0.8972 High Similarity NPC63841
0.8962 High Similarity NPC307660
0.8962 High Similarity NPC130511
0.8909 High Similarity NPC132668
0.8879 High Similarity NPC186054
0.8818 High Similarity NPC473352
0.8807 High Similarity NPC471093
0.8796 High Similarity NPC189663
0.8796 High Similarity NPC89860
0.875 High Similarity NPC88945
0.8739 High Similarity NPC471252
0.8727 High Similarity NPC29505
0.8716 High Similarity NPC118721
0.8716 High Similarity NPC252679
0.8704 High Similarity NPC471461
0.8704 High Similarity NPC67745
0.8684 High Similarity NPC469488
0.8649 High Similarity NPC11252
0.8649 High Similarity NPC289312
0.8636 High Similarity NPC471476
0.8636 High Similarity NPC474567
0.8624 High Similarity NPC55973
0.8624 High Similarity NPC232133
0.8609 High Similarity NPC476961
0.8598 High Similarity NPC139347
0.8596 High Similarity NPC297179
0.8596 High Similarity NPC188667
0.8596 High Similarity NPC204552
0.8585 High Similarity NPC14634
0.8584 High Similarity NPC229752
0.8559 High Similarity NPC263827
0.8559 High Similarity NPC63244
0.8559 High Similarity NPC285410
0.8559 High Similarity NPC250481
0.8559 High Similarity NPC201992
0.8545 High Similarity NPC469983
0.8534 High Similarity NPC102822
0.8534 High Similarity NPC477046
0.8532 High Similarity NPC166993
0.8519 High Similarity NPC202793
0.8509 High Similarity NPC122033
0.8509 High Similarity NPC470854
0.8509 High Similarity NPC287343
0.8509 High Similarity NPC473304
0.8509 High Similarity NPC474654
0.8509 High Similarity NPC78836
0.8509 High Similarity NPC97908
0.85 High Similarity NPC476966
0.8496 Intermediate Similarity NPC18547
0.8496 Intermediate Similarity NPC474906
0.8496 Intermediate Similarity NPC116024
0.8482 Intermediate Similarity NPC157929
0.8482 Intermediate Similarity NPC471244
0.8482 Intermediate Similarity NPC145625
0.8475 Intermediate Similarity NPC473255
0.8468 Intermediate Similarity NPC473324
0.8468 Intermediate Similarity NPC129340
0.8455 Intermediate Similarity NPC293850
0.8455 Intermediate Similarity NPC273155
0.8448 Intermediate Similarity NPC112038
0.844 Intermediate Similarity NPC200957
0.844 Intermediate Similarity NPC138908
0.8435 Intermediate Similarity NPC17772
0.8435 Intermediate Similarity NPC239293
0.8426 Intermediate Similarity NPC209298
0.8426 Intermediate Similarity NPC159442
0.8426 Intermediate Similarity NPC122811
0.8426 Intermediate Similarity NPC277074
0.8421 Intermediate Similarity NPC134869
0.8421 Intermediate Similarity NPC44170
0.8421 Intermediate Similarity NPC152199
0.8421 Intermediate Similarity NPC235539
0.8417 Intermediate Similarity NPC245094
0.8407 Intermediate Similarity NPC49451
0.8407 Intermediate Similarity NPC471248
0.8407 Intermediate Similarity NPC238935
0.8407 Intermediate Similarity NPC251309
0.8407 Intermediate Similarity NPC208998
0.8407 Intermediate Similarity NPC194100
0.8407 Intermediate Similarity NPC51978
0.8407 Intermediate Similarity NPC475208
0.8407 Intermediate Similarity NPC94141
0.8407 Intermediate Similarity NPC7921
0.8407 Intermediate Similarity NPC255017
0.8403 Intermediate Similarity NPC174367
0.8403 Intermediate Similarity NPC47113
0.8393 Intermediate Similarity NPC122339
0.8393 Intermediate Similarity NPC56025
0.8378 Intermediate Similarity NPC265655
0.8378 Intermediate Similarity NPC218853
0.8378 Intermediate Similarity NPC143706
0.8378 Intermediate Similarity NPC472534
0.8376 Intermediate Similarity NPC202051
0.8364 Intermediate Similarity NPC293512
0.8362 Intermediate Similarity NPC470777
0.8362 Intermediate Similarity NPC473203
0.8362 Intermediate Similarity NPC475775
0.8362 Intermediate Similarity NPC476529
0.8349 Intermediate Similarity NPC96268
0.8349 Intermediate Similarity NPC301787
0.8348 Intermediate Similarity NPC309433
0.8348 Intermediate Similarity NPC300419
0.8348 Intermediate Similarity NPC470959
0.8348 Intermediate Similarity NPC474483
0.8348 Intermediate Similarity NPC473968
0.8348 Intermediate Similarity NPC477252
0.8348 Intermediate Similarity NPC476965
0.8333 Intermediate Similarity NPC17165
0.8333 Intermediate Similarity NPC470882
0.8333 Intermediate Similarity NPC471398
0.8333 Intermediate Similarity NPC470953
0.8333 Intermediate Similarity NPC473882
0.8319 Intermediate Similarity NPC177820
0.8319 Intermediate Similarity NPC7850
0.8319 Intermediate Similarity NPC6615
0.8319 Intermediate Similarity NPC248202
0.8319 Intermediate Similarity NPC48249
0.8319 Intermediate Similarity NPC470922
0.8319 Intermediate Similarity NPC80843
0.8319 Intermediate Similarity NPC1046
0.8319 Intermediate Similarity NPC302146
0.8319 Intermediate Similarity NPC233003
0.8319 Intermediate Similarity NPC473303
0.8319 Intermediate Similarity NPC30188
0.8319 Intermediate Similarity NPC130229
0.8319 Intermediate Similarity NPC471245
0.8318 Intermediate Similarity NPC470388
0.8305 Intermediate Similarity NPC470265
0.8305 Intermediate Similarity NPC471965
0.8305 Intermediate Similarity NPC23786
0.8293 Intermediate Similarity NPC316915
0.8291 Intermediate Similarity NPC109607
0.8291 Intermediate Similarity NPC473645
0.8291 Intermediate Similarity NPC107338
0.8291 Intermediate Similarity NPC471406
0.8288 Intermediate Similarity NPC195708
0.8288 Intermediate Similarity NPC258323
0.8288 Intermediate Similarity NPC272576
0.8276 Intermediate Similarity NPC251310
0.8276 Intermediate Similarity NPC105800
0.8276 Intermediate Similarity NPC232237
0.8273 Intermediate Similarity NPC102352
0.8273 Intermediate Similarity NPC222833
0.8264 Intermediate Similarity NPC473620
0.8261 Intermediate Similarity NPC96312
0.8261 Intermediate Similarity NPC476963
0.8261 Intermediate Similarity NPC328374
0.8261 Intermediate Similarity NPC37134
0.8261 Intermediate Similarity NPC244127
0.8261 Intermediate Similarity NPC251236
0.8261 Intermediate Similarity NPC268954
0.8261 Intermediate Similarity NPC291903
0.8261 Intermediate Similarity NPC40632
0.8257 Intermediate Similarity NPC96217
0.825 Intermediate Similarity NPC473635
0.825 Intermediate Similarity NPC285091
0.825 Intermediate Similarity NPC293112
0.8246 Intermediate Similarity NPC73986
0.8246 Intermediate Similarity NPC260665
0.8241 Intermediate Similarity NPC236585
0.8241 Intermediate Similarity NPC252614
0.8235 Intermediate Similarity NPC471964
0.8235 Intermediate Similarity NPC469789
0.8235 Intermediate Similarity NPC262199
0.8235 Intermediate Similarity NPC11895
0.8235 Intermediate Similarity NPC471961
0.8235 Intermediate Similarity NPC202666
0.8235 Intermediate Similarity NPC14617
0.823 Intermediate Similarity NPC472003
0.823 Intermediate Similarity NPC31839
0.823 Intermediate Similarity NPC146945
0.823 Intermediate Similarity NPC292196
0.823 Intermediate Similarity NPC179434
0.823 Intermediate Similarity NPC171888
0.8224 Intermediate Similarity NPC474793
0.822 Intermediate Similarity NPC476204
0.822 Intermediate Similarity NPC475182
0.822 Intermediate Similarity NPC170084
0.822 Intermediate Similarity NPC67569

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC320118 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8291 Intermediate Similarity NPD6319 Approved
0.8235 Intermediate Similarity NPD8328 Phase 3
0.8053 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.8017 Intermediate Similarity NPD7492 Approved
0.7983 Intermediate Similarity NPD6054 Approved
0.7967 Intermediate Similarity NPD7736 Approved
0.7951 Intermediate Similarity NPD6616 Approved
0.7931 Intermediate Similarity NPD4632 Approved
0.7917 Intermediate Similarity NPD6016 Approved
0.7917 Intermediate Similarity NPD6015 Approved
0.7886 Intermediate Similarity NPD7078 Approved
0.7881 Intermediate Similarity NPD6009 Approved
0.7881 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD7115 Discovery
0.7876 Intermediate Similarity NPD6412 Phase 2
0.7851 Intermediate Similarity NPD5988 Approved
0.7851 Intermediate Similarity NPD6370 Approved
0.7845 Intermediate Similarity NPD8297 Approved
0.7845 Intermediate Similarity NPD6882 Approved
0.776 Intermediate Similarity NPD7319 Approved
0.7759 Intermediate Similarity NPD6649 Approved
0.7759 Intermediate Similarity NPD6650 Approved
0.7719 Intermediate Similarity NPD5697 Approved
0.7686 Intermediate Similarity NPD6059 Approved
0.7672 Intermediate Similarity NPD4634 Approved
0.7661 Intermediate Similarity NPD7507 Approved
0.7652 Intermediate Similarity NPD6881 Approved
0.7652 Intermediate Similarity NPD6686 Approved
0.7652 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7652 Intermediate Similarity NPD6899 Approved
0.76 Intermediate Similarity NPD8293 Discontinued
0.7586 Intermediate Similarity NPD6373 Approved
0.7586 Intermediate Similarity NPD6013 Approved
0.7586 Intermediate Similarity NPD6014 Approved
0.7586 Intermediate Similarity NPD6372 Approved
0.7586 Intermediate Similarity NPD6012 Approved
0.7521 Intermediate Similarity NPD7102 Approved
0.7521 Intermediate Similarity NPD7290 Approved
0.7521 Intermediate Similarity NPD6883 Approved
0.75 Intermediate Similarity NPD6011 Approved
0.748 Intermediate Similarity NPD8516 Approved
0.748 Intermediate Similarity NPD8513 Phase 3
0.748 Intermediate Similarity NPD5983 Phase 2
0.748 Intermediate Similarity NPD8517 Approved
0.748 Intermediate Similarity NPD8515 Approved
0.7479 Intermediate Similarity NPD8133 Approved
0.7478 Intermediate Similarity NPD5739 Approved
0.7478 Intermediate Similarity NPD6675 Approved
0.7478 Intermediate Similarity NPD7128 Approved
0.7478 Intermediate Similarity NPD6402 Approved
0.7458 Intermediate Similarity NPD8130 Phase 1
0.7458 Intermediate Similarity NPD6617 Approved
0.7458 Intermediate Similarity NPD6869 Approved
0.7458 Intermediate Similarity NPD6847 Approved
0.7431 Intermediate Similarity NPD6399 Phase 3
0.7414 Intermediate Similarity NPD5701 Approved
0.736 Intermediate Similarity NPD7604 Phase 2
0.735 Intermediate Similarity NPD7320 Approved
0.7345 Intermediate Similarity NPD5286 Approved
0.7345 Intermediate Similarity NPD4696 Approved
0.7345 Intermediate Similarity NPD5285 Approved
0.7339 Intermediate Similarity NPD6079 Approved
0.7339 Intermediate Similarity NPD7503 Approved
0.7328 Intermediate Similarity NPD6008 Approved
0.7321 Intermediate Similarity NPD7902 Approved
0.7317 Intermediate Similarity NPD7516 Approved
0.7288 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD8294 Approved
0.7258 Intermediate Similarity NPD8377 Approved
0.7257 Intermediate Similarity NPD4225 Approved
0.7244 Intermediate Similarity NPD6336 Discontinued
0.7236 Intermediate Similarity NPD7327 Approved
0.7236 Intermediate Similarity NPD7328 Approved
0.7232 Intermediate Similarity NPD5222 Approved
0.7232 Intermediate Similarity NPD5221 Approved
0.7232 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7227 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD5224 Approved
0.7217 Intermediate Similarity NPD5211 Phase 2
0.7217 Intermediate Similarity NPD5225 Approved
0.7217 Intermediate Similarity NPD4633 Approved
0.7217 Intermediate Similarity NPD5226 Approved
0.7207 Intermediate Similarity NPD7748 Approved
0.72 Intermediate Similarity NPD8033 Approved
0.72 Intermediate Similarity NPD8380 Approved
0.72 Intermediate Similarity NPD8379 Approved
0.72 Intermediate Similarity NPD8335 Approved
0.72 Intermediate Similarity NPD8378 Approved
0.72 Intermediate Similarity NPD8296 Approved
0.7196 Intermediate Similarity NPD3618 Phase 1
0.7182 Intermediate Similarity NPD6411 Approved
0.7182 Intermediate Similarity NPD7515 Phase 2
0.7168 Intermediate Similarity NPD5173 Approved
0.7168 Intermediate Similarity NPD4755 Approved
0.7156 Intermediate Similarity NPD5328 Approved
0.7155 Intermediate Similarity NPD5174 Approved
0.7155 Intermediate Similarity NPD5175 Approved
0.7132 Intermediate Similarity NPD6033 Approved
0.713 Intermediate Similarity NPD5223 Approved
0.713 Intermediate Similarity NPD3573 Approved
0.7105 Intermediate Similarity NPD7638 Approved
0.7094 Intermediate Similarity NPD5141 Approved
0.708 Intermediate Similarity NPD4697 Phase 3
0.7073 Intermediate Similarity NPD6274 Approved
0.7063 Intermediate Similarity NPD6921 Approved
0.7059 Intermediate Similarity NPD4729 Approved
0.7059 Intermediate Similarity NPD4730 Approved
0.7054 Intermediate Similarity NPD8074 Phase 3
0.7054 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD7900 Approved
0.7043 Intermediate Similarity NPD7639 Approved
0.7043 Intermediate Similarity NPD4700 Approved
0.7043 Intermediate Similarity NPD7640 Approved
0.704 Intermediate Similarity NPD7101 Approved
0.704 Intermediate Similarity NPD7100 Approved
0.7027 Intermediate Similarity NPD8035 Phase 2
0.7027 Intermediate Similarity NPD8034 Phase 2
0.7025 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD6083 Phase 2
0.7018 Intermediate Similarity NPD6084 Phase 2
0.7016 Intermediate Similarity NPD6317 Approved
0.7 Intermediate Similarity NPD6101 Approved
0.7 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.6991 Remote Similarity NPD5695 Phase 3
0.6975 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6964 Remote Similarity NPD4202 Approved
0.696 Remote Similarity NPD6314 Approved
0.696 Remote Similarity NPD6335 Approved
0.696 Remote Similarity NPD6313 Approved
0.6957 Remote Similarity NPD5696 Approved
0.6942 Remote Similarity NPD5250 Approved
0.6942 Remote Similarity NPD5251 Approved
0.6942 Remote Similarity NPD5249 Phase 3
0.6942 Remote Similarity NPD5247 Approved
0.6942 Remote Similarity NPD5248 Approved
0.6935 Remote Similarity NPD6868 Approved
0.6929 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6894 Remote Similarity NPD5956 Approved
0.6891 Remote Similarity NPD4767 Approved
0.6891 Remote Similarity NPD4768 Approved
0.6885 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6881 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6875 Remote Similarity NPD5284 Approved
0.6875 Remote Similarity NPD5281 Approved
0.6852 Remote Similarity NPD4786 Approved
0.6842 Remote Similarity NPD4629 Approved
0.6842 Remote Similarity NPD5210 Approved
0.6822 Remote Similarity NPD3667 Approved
0.6822 Remote Similarity NPD6067 Discontinued
0.6814 Remote Similarity NPD5778 Approved
0.6814 Remote Similarity NPD5779 Approved
0.6807 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6803 Remote Similarity NPD6371 Approved
0.6791 Remote Similarity NPD8338 Approved
0.6789 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6777 Remote Similarity NPD5128 Approved
0.6757 Remote Similarity NPD6672 Approved
0.6757 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6757 Remote Similarity NPD5737 Approved
0.6754 Remote Similarity NPD5282 Discontinued
0.6748 Remote Similarity NPD5215 Approved
0.6748 Remote Similarity NPD5217 Approved
0.6748 Remote Similarity NPD5216 Approved
0.6742 Remote Similarity NPD8336 Approved
0.6742 Remote Similarity NPD8337 Approved
0.6727 Remote Similarity NPD6684 Approved
0.6727 Remote Similarity NPD7334 Approved
0.6727 Remote Similarity NPD6409 Approved
0.6727 Remote Similarity NPD7521 Approved
0.6727 Remote Similarity NPD5330 Approved
0.6727 Remote Similarity NPD7146 Approved
0.6726 Remote Similarity NPD7983 Approved
0.6723 Remote Similarity NPD4754 Approved
0.6716 Remote Similarity NPD7260 Phase 2
0.6697 Remote Similarity NPD3665 Phase 1
0.6697 Remote Similarity NPD3133 Approved
0.6697 Remote Similarity NPD3666 Approved
0.6696 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6696 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6696 Remote Similarity NPD4753 Phase 2
0.6667 Remote Similarity NPD5169 Approved
0.6667 Remote Similarity NPD6334 Approved
0.6667 Remote Similarity NPD5135 Approved
0.6667 Remote Similarity NPD6908 Approved
0.6667 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6909 Approved
0.6667 Remote Similarity NPD6333 Approved
0.6641 Remote Similarity NPD4522 Approved
0.6639 Remote Similarity NPD5168 Approved
0.6637 Remote Similarity NPD6698 Approved
0.6637 Remote Similarity NPD46 Approved
0.6636 Remote Similarity NPD1694 Approved
0.6613 Remote Similarity NPD5127 Approved
0.6607 Remote Similarity NPD6903 Approved
0.6579 Remote Similarity NPD7637 Suspended
0.6577 Remote Similarity NPD5279 Phase 3
0.656 Remote Similarity NPD6053 Discontinued
0.6555 Remote Similarity NPD5344 Discontinued
0.6525 Remote Similarity NPD8029 Clinical (unspecified phase)
0.65 Remote Similarity NPD7632 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data